HBV Antivirals

HBV antivirals are prescription medications used to treat chronic hepatitis B virus (HBV) infection. Oral options include tenofovir disoproxil fumarate (Viread), tenofovir alafenamide (Vemlidy), and entecavir (Baraclude), which block the virus from replicating. Pegylated interferon alfa-2a (Pegasys) works differently, boosting the immune system's response against HBV-infected cells. Talk with your liver specialist to see which option fits your treatment plan.

Oral antivirals like Viread, Vemlidy, and Baraclude directly block hepatitis B viral DNA replication in liver cells, which reduces viral load and helps decrease liver inflammation over time. Pegasys instead stimulates the immune system to fight HBV-infected cells, which may lead to sustained viral suppression or, in some patients, HBeAg seroconversion. Your healthcare provider can explain how each mechanism applies to your specific situation.

Providers typically consider HBV antivirals for adults with chronic hepatitis B who need long-term viral suppression, who are at risk of progressing to cirrhosis or liver cancer, or who need treatment to reduce ongoing liver inflammation. Pegasys may be an option for people who prefer a finite treatment course or who are not suitable candidates for oral therapy. Eligibility depends on your viral activity, liver health, and overall health history, so only a qualified healthcare provider can determine the right therapy for you.

Viread, Vemlidy, and Baraclude are taken as daily tablets and are generally used long-term or indefinitely, for as long as viral suppression is needed and the medication is well tolerated. Pegasys is given as a weekly injection over a finite, time-limited course, typically ranging from several months up to about 48 weeks. Your provider will individualize duration based on how your body responds and how well you tolerate treatment.

Common side effects of oral antivirals (Viread, Vemlidy, Baraclude) include headache, fatigue, nausea, and elevated liver enzymes that require monitoring. Pegasys commonly causes flu-like symptoms such as fever, chills, and muscle aches, along with injection site reactions and, in some cases, mood changes or changes in blood counts. Your healthcare provider will monitor you regularly and can help manage any side effects that arise.

No, HBV antiviral therapy works alongside lifestyle changes rather than replacing them. Avoiding alcohol, maintaining a balanced diet, managing weight, and following infection-control precautions remain essential parts of hepatitis B care. These medications help suppress the virus and protect the liver, but they work best when combined with these ongoing habits. Ask your healthcare provider how to build a plan that pairs medication with lifestyle support.

No. Regular monitoring of HBV viral load and liver function tests helps confirm the virus remains suppressed and flags any changes early, but it does not replace the antiviral medication itself. For oral antivirals, treatment is usually continued long-term or indefinitely; stopping without medical guidance can allow the virus to become active again. Always talk with your healthcare provider before making any changes to your treatment plan.